Frequently Asked Questions
Questions? We’ve got answers.
What are the components of the Secure Testing, Inc. eScreen Drugs-of-Abuse Screening system?
The eCup/eReader rapid drug-testing system simplifies the tasks we use to perform when collecting urine specimens. Together, the two reduce labor and unnecessary errors that can occur in non-automated testing processes. Specifically, when you employ Secure Testing, Inc. for your point-of-collection drug testing, you eliminate interpretation and transcription errors, ensuring complete objectivity of the test procedure. Our eReader also eliminates confidentiality concerns at the clinic because no one at the clinic can see the test results. Less labor, less cost, fewer errors.
What are the benefits of Secure Testing, Inc. eScreen123?
Our eScreen123 software is designed to eliminate unnecessary manual steps in drug-testing and other collection process. It will save you time and money and improve service to your employees. For example, eScreen123 creates an electronic chain-of-custody form (we call it an eCCF). Having a digital version of this form eliminates all the errors and waste caused by printing, faxing, delivering, storing, mailing, entering data and completing forms manually. These manual processes represent $3 to $5 of the cost per test you end up eliminating when using our paperless system. In addition, the eScreen123 software solution can manage all types of hiring programs: DOT, non-DOT, rapid testing, lab-based testing, breath-alcohol testing and more. Specifically:
- mCup manual rapid testing. Our manually performed rapid drug screen provides employers with the fast turn-around time of rapid testing with an expanded test panel option. The mCup is available in a variety of test panel configurations, including 5-, 7-, 9-, and 10-panel options. It also utilizes both our electronic chain of custody form and our web-based result reporting.
- DOT lab-based testing. We designed eScreen to electronically manage DOT drug-test results on MyeScreen.com so that it digitally captures data for reports and other statistical functions. We do our best to ease the responsibilities of those with regulated programs.
- Non-DOT lab-based testing. For employers who are not eligible to use eCup tests, the eScreen solution can still process all lab-based collections. Using our service allows our customers to gain from a paperless chain of custody, along with accessing all results electronically via MyeScreen.com.
- Breath-alcohol testing. The eScreen process can also capture, report results and maintain statistics on breath-alcohol tests for our employers, as well.
What are the benefits of using the eReader and the eCup?
The eCup/eReader rapid drug-testing system simplifies the tasks Secure Testing, Inc. uses to perform when collecting urine specimens. Together, the two reduce labor and unnecessary errors that can occur in non-automated testing processes. Specifically, we employ point-of-collection drug testing, that eliminate interpretation and transcription errors, ensuring complete objectivity of the test procedure. Our eReader also eliminates confidentiality concerns at the clinic because no one at your clinic can see the test results.. Less labor, less cost, fewer errors.
What are the benefits of using MyeScreen.com in conjunction with eScreen123?
The benefits are multiple. First, the two systems work together to send test results from our clinic to our customer in less than 15 minutes (for all nonpositive results). Second, the two systems eliminate the time-consuming chore of having to fax results manually to our clients. Plus, because MyeScreen.com is a total-solution, program-management website, users gain from features such as test-event scheduling, donor and specimen tracking and monitoring, and sophisticated customer-report generation.
How long does it take to get results with the eScreen drug testing system?
How fast does it take you to go get a refill of your morning cup of coffee? We’re probably faster! The eReader testing process takes about 3 to 8 minutes. Once we place the eCup into the eReader, data immediately begins to transmit over eScreen’s proprietary network to our customer. This ability automates and accelerates the hiring process for employers by providing negative drug test results to the client’s MyeScreen.com account within 15 minutes of test completion.
Can I use eScreen to manage my manual DOT testing processes?
Yes. You can log the results of DOT tests and manual collections into eScreen123, which records and organizes the data. Plus, the eScreen123 software ensures you follow all of the proper collection steps. (Note: Per DOT regulations, a paper chain of custody must accompany the test to the lab.) In addition, eScreen can report all DOT test results to the employer once the specimen has been tested at the lab and an MRO has confirmed it. For companies that have fragmented programs that include both DOT and non-DOT testing, eScreen can consolidate the reporting of all these results.
How is specimen validity testing handled with rapid drug testing?
We’ve designed the lid of our eCup to include a built-in specimen-validity profile. This built-in test strip identifies any donor tampering. The eReader also provides interpretation documentation of possible tampering by testing for nitrites, pH and creatinine in the specimen.
Why is Secure Testing, Inc. eScreen's eCup a five-panel test vs. a seven- or 10-panel test?
A seven-panel and 10-panel test includes testing for drugs such as barbiturates, benzodiazepines and methaqualones. The value of testing for these drugs is debatable. Consider these statistics: From January to June 2003, drug-test results found only a 0.04 percent positivity rate for benzodiazepine, 0 percent positivity rate for methaqualones and 0.03 percent positivity rate for barbiturates. About 76 percent of barbiturates and 67 percent of benzodiazepines were overturned by MROs (medical review officers) based on the donor being on legitimate prescription drugs. Thus, focusing on a five-panel test eliminates the unnecessary delay you are likely to experience when an MRO ends up overturning a positive result due to legitimate prescription medications.